Company: VRCA
Filing Date: 2025-12-23
Form Type: 424B3
Source: 0001193125-25-330986
Chunk: 9

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-12-23
Form: 424B3
Chunk 9
---
 |              |    58,943 |     |                        |         — |     | —     |

7

| * | Represents beneficial ownership of less than 1% |

| (1) | Represents all of the shares of our common stock that the selling stockholders may offer and sell from time to 
 time under this prospectus without giving effect to the beneficial ownership limitation in the Warrants.       |

| (2) | Assumes each selling stockholder sells the maximum number of Resale Shares possible in this offering. |

| (3) | “Beneficial Ownership Prior to this Offering” consists of (a) 1,375,380 shares of our common stock                                                                                                                                                        
 issued to Paul and Diane Manning, JTWROS in the Private Placement, (b) 2,750,762 shares of our common stock issued to BKB Growth Investments, LLC (“BKB”) in the Private Placement, (c) 343,845 shares of our common stock issuable upon                  
 exercise of Common Warrants issued to Paul and Diane Manning, JTWROS in the Private Placement, (d) 687,690 shares of our common stock issuable upon exercise of Common Warrants issued to BKB in the Private Placement, (e) 2,582,809 shares of our       
 common stock held by Paul and Diane Manning, JTWROS prior to the Private Placement, (f) 597,610 shares of our common stock held by BKB prior to the Private Placement, (g) 332,433 shares of common stock held by The Paul B. Manning Revocable Trust     
 dated May 10, 2000 prior to the Private Placement, (h) 267,561 shares of common stock held by separate trusts for the benefit of Paul B. Manning’s immediate family members prior to the Private Placement, (i) 25,663 shares of common stock             
 held by PBM Capital Investments, LLC (“PBMCI”) prior to the Private Placement, (j) 921,348 shares of our common stock issuable upon exercise of Series B warrants held by Paul and Diane Manning, JTWROS prior to the Private Placement and               
 (k) 224,719 shares of our common stock issuable upon exercise of Series B warrants held by BKB prior to the Private Placement (collectively with (c), (d) and (j), the “Manning Warrants”). Pursuant to the terms of the Manning Warrants,                
 the holder of such Manning Warrants does not